GLP-1 Market
LLY $1351.12 ▼ -2.3% NVO $38.87 ▼ -1.4% PFE $27.54 ▼ -1.9% VKTX $25.84 ▼ -1.3% KLRA $11.58 ▼ -1.8% GPCR $17.12 ▼ -1.4% RHHBY $58.99 ▼ -0.9%
Market data delayed up to 20 min · Source: Twelve Data
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Omega-3-Acid Ethyl Esters

Company
National Cancer Institute (NCI)
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
3 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

3 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Nov 20, 2026

Find a Clinical Trial Near Me

See recruiting studies for Omega-3-Acid Ethyl Esters and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT06195306

    Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction

    Not yet reported National Cancer Institute (NCI) 66 participants Est. completion 2028-01-01 3 sites Stand-alone
    Other conditions: Breast Atypical Hyperplasia, Breast Carcinoma, Breast Ductal Carcinoma In Situ, Breast Lobular Carcinoma In Situ
    View official trial listing →
  • Recruiting NCT NCT07078422

    Home Use Study of Targeted Mechanical Stimulation for Tremor Relief

    Not yet reported Encora, Inc. 80 participants Est. completion 2026-06 1 site
    Other conditions: Essential Tremor, Parkinson's Disease
    View official trial listing →
  • Recruiting NCT NCT07911488

    The Encora X1™ in a Real World Observational Study

    Encora, Inc. 1000 participants Est. completion 2032-08 1 site
    Other conditions: Essential Tremor
    View official trial listing →
  • Completed NCT NCT00004448

    Alternate Day Prednisone or Daily Fish Oil Supplements in Patients With Immunoglobulin A Nephropathy

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 96 participants Est. completion 2007-08 1 site
    Other conditions: IgA Glomerulonephritis
    View official trial listing →
  • Completed NCT NCT00069784

    The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention)

    Not yet reported Sanofi 12537 participants Est. completion 2011-12 40 sites
    Other conditions: Diabetes Mellitus, Non-Insulin-Dependent
    View official trial listing →
  • Active, not recruiting NCT NCT00135226

    ASCEND: A Study of Cardiovascular Events iN Diabetes

    Not yet reported University of Oxford 15480 participants Est. completion 2037-07-31 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00149409

    Omega-3-Polyunsaturated Fatty-Acids (N3-Pufa) In Patients With Severe Chronic Heart Failure

    Not yet reported, Not yet reported Medical University of Vienna Est. completion 2008-02 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT00246636

    Evaluation of Efficacy and Safety of Omacor (Omega-3-acid Ethyl Esters) as Add-on Therapy in Hypertriglyceridemic Subjects Treated With Antara (Fenofibrate) Followed by an 8-week Extension

    Not yet reported GlaxoSmithKline 167 participants Est. completion 2007-03 Stand-alone
    Other conditions: Hypertriglyceridemia
    View official trial listing →
  • Completed NCT NCT00246701

    Evaluation of Efficacy and Safety of Combined Omacor (Omega-3-acid Ethyl Esters) and Simvastatin Therapy in Hypertriglyceridemic Subjects

    Not yet reported GlaxoSmithKline 256 participants Est. completion 2006-06-01 Stand-alone
    Other conditions: Hypertriglyceridemia
    View official trial listing →
  • Completed NCT NCT00251134

    OMEGA-Study: Effect of Omega 3-Fatty Acids on the Reduction of Sudden Cardiac Death After Myocardial Infarction

    Not yet reported Stiftung Institut fuer Herzinfarktforschung 3800 participants Est. completion 2008-09 10 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00257283

    Omacor in Prevention of Cardiovascular Events in Patients Undergoing Chronic Hemodialysis

    Not yet reported Pronova BioPharma 200 participants Est. completion 2005-06 1 site
    Other conditions: Kidney Failure, Chronic
    View official trial listing →
  • Completed NCT NCT00286234

    Niacin, N-3 Fatty Acids and Insulin Resistance

    Not yet reported University of South Dakota 68 participants Est. completion 2008-12 1 site Stand-alone
    Metabolic syndrome Other conditions: Hypertriglyceridemia
    View official trial listing →
  • Completed NCT NCT00294216

    Omacor and Placebo in Carotid Plaque Stability

    Not yet reported Pronova BioPharma 121 participants Est. completion 2005-07 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00296153

    Omacor and Cardiovascular Risk Factors in HIV Patients on HAART Treatment

    Not yet reported Pronova BioPharma 51 participants Est. completion 2007-10 1 site
    Other conditions: Human Immunodeficiency Virus, Ischemic Heart Disease
    View official trial listing →
  • Completed NCT NCT00328536

    Omacor for the Treatment of Vascular Dysfunction in Patients With Type 2 Diabetes Mellitus

    Not yet reported Ruhr University of Bochum 34 participants Est. completion 2008-11 1 site
    Type 2 diabetes Other conditions: Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00346697

    Omega-3 Fatty Acids for High Triglycerides in HIV-infected Patients

    Not yet reported Brown, Todd, M.D., Ph.D. 48 participants Est. completion 2010-04 3 sites Stand-alone
    Other conditions: HIV Infections, AIDS, Dyslipidemia, Hypertriglyceridemia
    View official trial listing →
  • Completed NCT NCT00402363

    Evaluation of Efficacy and Safety of Lovaza (Omega-3-Acid Ethyl Esters) in Recurrent, Symptomatic Atrial Fibrillation

    Not yet reported GlaxoSmithKline 663 participants Est. completion 2010-01 178 sites Stand-alone
    Other conditions: Fibrillation, Atrial
    View official trial listing →
  • Completed NCT NCT00435045

    Evaluation of Efficacy and Safety of Omacor, Co-Administered With Atorvastatin, in Subjects With Hypertriglyceridemia

    Not yet reported GlaxoSmithKline 245 participants Est. completion 2007-10 Stand-alone
    Other conditions: Hypertriglyceridemia
    View official trial listing →
  • Status unknown NCT NCT00437099

    Efficacy of Omega-3 Fatty Acids on Borderline Personality Disorder

    Not yet reported Hospital Universitari Vall d'Hebron Research Institute 102 participants Est. completion 2011-09 1 site
    Other conditions: Borderline Personality Disorder.
    View official trial listing →
  • Completed NCT NCT00446966

    Fish Oil for Reduction of Atrial Fibrillation After Cardiac Surgery

    Not yet reported Chirag Sandesara 260 participants Est. completion 2010-01 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT00454493

    The Effect of Fish Oil Supplementation on Endothelial Function, Heart Rate Variability and Intimal Media Thickness of Patients With Coronary Artery Disease

    Not yet reported Olive View-UCLA Education & Research Institute 71 participants Est. completion 2008-12 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00487591

    An Evaluation of Simvastatin Plus Omacor Compared to Simvastatin Plus Placebo in Subjects With Mixed Dyslipidemia

    Provident Clinical Research 40 participants Est. completion 2007-08
    Other conditions: Mixed Dyslipidemia
    View official trial listing →
  • Completed NCT NCT00504309

    Vascular and Lipid Effects of Omega-3 Fatty Acids in People With Moderately Elevated Triglycerides

    Not yet reported Penn State University 28 participants Est. completion 2009-01 1 site
    Other conditions: Hypertriglyceridemia
    View official trial listing →
  • Withdrawn NCT NCT00507390

    Omega 3 Polyunsaturated Fatty Acid Supplements (PUFAs) and Microvolt T Wave Alternans (TWA) in Patients With Ventricular Arrhythmia

    Not yet reported University of Dundee Est. completion 2008-08 1 site
    Other conditions: Arrhythmia, Defibrillators, Implantable
    View official trial listing →
  • Withdrawn NCT NCT00508248

    Omega 3 Fatty Acids and Atrial Fibrillation

    Not yet reported University of Dundee Est. completion 2008-11 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT00515541

    Lovaza's Effect on the Activation of Platelets

    Not yet reported Invitrox 43 participants Est. completion 2009-06
    Cardiovascular disease Other conditions: Bleeding
    View official trial listing →
  • Withdrawn NCT NCT00517972

    Omacor for Perimenopausal Depression

    Not yet reported University of Arizona 1 site
    Other conditions: Depression
    View official trial listing →
  • Withdrawn NCT NCT00547716

    Use of Omega-3 Fatty Acids (Fish Oil) in Patients With Chronic Hepatitis C Infection

    Not yet reported University of Missouri, Kansas City Est. completion 2012-08 2 sites
    Other conditions: Hepatitis C
    View official trial listing →
  • Completed NCT NCT00549692

    Efficacy and Safety of Omega-3 Fatty Acids(Omacor®) for the Treatment of Immunoglobulin A Nephropathy

    Not yet reported Kuhnil Pharmaceutical Co., Ltd. 152 participants Est. completion 2012-09 5 sites
    Other conditions: IgA Nephropathy
    View official trial listing →
  • Completed NCT NCT00552084

    Evaluating the Effectiveness of Fish Oil Supplements at Reducing the Recurrence of Atrial Fibrillation

    Not yet reported Vanderbilt University 190 participants Est. completion 2014-04 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Withdrawn NCT NCT00569686

    Lovaza Therapy of Peripheral Arterial Disease

    Not yet reported University of Virginia Est. completion 2010-02 1 site
    Other conditions: Peripheral Artery Disease
    View official trial listing →
  • Completed NCT NCT00577590

    Effects of Fatty Acid Delivery on Heart Metabolism and Function in Type 2 Diabetes (T2DM

    Not yet reported Washington University School of Medicine 78 participants Est. completion 2012-09 1 site Stand-alone
    Other conditions: Diabetes Mellitus, Type II
    View official trial listing →
  • Completed NCT NCT00579436

    Effects of Fish Oils on Inflammation and Insulin Resistance

    Not yet reported Philip Kern 33 participants Est. completion 2015-01-15 1 site
    Metabolic syndrome Other conditions: Insulin Resistance
    View official trial listing →
  • Terminated NCT NCT00598910

    Effect of Omacor on Triglycerides in HIV Infected Subjects

    Not yet reported Solvay Pharmaceuticals 51 participants Est. completion 2009-03 5 sites
    Other conditions: Hyper-Triglyceridemia
    View official trial listing →
  • Terminated NCT NCT00672633

    Trial of Lovaza in Adolescents With Mild to Moderately Elevated Triglycerides

    Not yet reported Boston Children's Hospital 25 participants Est. completion 2012-03 1 site Stand-alone
    Other conditions: Hypertriglyceridemia
    View official trial listing →
  • Completed NCT NCT00678743

    An Open-label Extension to Assess the Continued Efficacy of Omacor Plus Simvastatin

    Not yet reported Provident Clinical Research 17 participants Est. completion 2009-09
    Other conditions: Dyslipidemias
    View official trial listing →
  • Active, not recruiting NCT NCT00682318

    Effects of Fish Oil and Red Wine on Oxidative Stress Biomarkers

    Not yet reported Carsten Skarke, MD 40 participants Est. completion 2029-11 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00688961

    Effects of Omacor and Aspirin on Platelet Function

    Not yet reported Sanford Research 10 participants Est. completion 2007-08 1 site
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT00694746

    Study of Fish Oil to Reduce ALT Levels in Adolescents

    Not yet reported Boston University 3 participants Est. completion 2014-03 1 site Stand-alone
    Other conditions: Non-alcoholic Fatty Liver Disease, Fatty Liver
    View official trial listing →
  • Completed NCT NCT00723398

    Nutritional Supplements and Hormonal Manipulations for Breast Cancer Prevention

    Not yet reported Milton S. Hershey Medical Center 266 participants Est. completion 2015-04 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00729430

    Effect of High Dose Fish Oil Supplementation After Recent Heart Attack Using Magnetic Resonance Imaging

    Not yet reported Brigham and Women's Hospital 358 participants Est. completion 2014-07 1 site
    Cardiovascular diseaseSubstance use disorder
    View official trial listing →
  • Terminated NCT NCT00743197

    Women With Chest Pain and Normal Coronary Arteries Study

    Not yet reported Northwestern University 3 participants Est. completion 2010-05 1 site
    Other conditions: Chest Pain
    View official trial listing →
  • Completed NCT NCT00746811

    Effects of Prescription Omega-3 on LDL-C in Primary Hypercholesterolemia

    Not yet reported Provident Clinical Research 32 participants Est. completion 2010-10 1 site
    Other conditions: Primary Hypercholesterolemia
    View official trial listing →
  • Status unknown NCT NCT00758927

    The Effects of Omega-3 Fatty Acid (OMACOR) on the Low-density Lipoprotein (LDL) Sub-fraction in Type 2 Diabetic Patients

    Not yet reported Inje University 70 participants Est. completion 2010-07 3 sites
    Type 2 diabetes Other conditions: Hypercholesterolemia, Hypertriglyceridemia
    View official trial listing →
  • Completed NCT NCT00760513

    Treatment of Non Alcoholic Fatty Liver Disease With n-3 Fatty Acids

    Not yet reported University Hospital Southampton NHS Foundation Trust 103 participants Est. completion 2018-11-29 1 site
    Other conditions: Non-Alcoholic Fatty Liver Disease
    View official trial listing →
  • Completed NCT NCT00760760

    n-3 Polyunsaturated Fatty Acids in Obesity

    Not yet reported Medical University of Vienna 55 participants Est. completion 2016-03 1 site
    Other conditions: Adipose Tissue Inflammation, Morbid Obesity
    View official trial listing →
  • Completed NCT NCT00771914

    The Effects of Omega-3 Fatty Acids on Aspirin Resistance

    Not yet reported, Not yet reported University of Rochester 27 participants Est. completion 2009-01 1 site Stand-alone
    Other conditions: Increased Drug Resistance
    View official trial listing →
  • Terminated NCT NCT00791089

    Effects of Fish Oil on Post Ablation Arrhythmias

    Not yet reported University of Michigan 12 participants Est. completion 2011-10 1 site Stand-alone
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT00794079

    Omega-3 Fatty Acids and Muscle Protein Synthesis

    Not yet reported Washington University School of Medicine 43 participants Est. completion 2010-12 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00795717

    Human Immunodeficiency Virus (HIV), Arterial Dysfunction, Lipids, Lovaza (HALO) Trial

    Not yet reported Tufts University 41 participants Est. completion 2010-10 1 site
    Cardiovascular disease Other conditions: HIV Infection
    View official trial listing →
  • Completed NCT NCT00805870

    The Effects of High Dose Fish Oil Supplementation on Delayed Onset Muscle Soreness and Inflammatory Markers

    Not yet reported Western Michigan University 20 participants Est. completion 2010-02 1 site Stand-alone
    Other conditions: Muscle Damage, Muscle Inflammation
    View official trial listing →
  • Completed NCT NCT00815685

    A Pilot Study of Eicosapentaenoic Acid (EPA) in Patients With Cancer Cachexia

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute 36 participants Est. completion 2010-08 2 sites Stand-alone
    Other conditions: Cancer Cachexia
    View official trial listing →
  • Completed NCT NCT00825994

    Omega-3 for Peri- and Postmenopausal Depression

    Not yet reported Massachusetts General Hospital 31 participants Est. completion 2009-06 1 site
    Other conditions: Depression
    View official trial listing →
  • Completed NCT NCT00828178

    Efficacy of Fish Oil in Lupus Patients

    Not yet reported Michelle Petri M.D.,MPH 106 participants Est. completion 2011-02 2 sites
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT00833976

    Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia

    Not yet reported Massachusetts General Hospital 65 participants Est. completion 2013-03 1 site Stand-alone
    Other conditions: High Triglycerides, Hypercholesterolemia, Schizophrenia, Schizoaffective Disorder, Bipolar Disorder
    View official trial listing →
  • No Longer Available NCT NCT00841451

    Pulmonary Vein Isolation Outcomes With Fish Oils

    St. Luke's-Roosevelt Hospital Center 3 sites
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Terminated NCT NCT00845845

    Fish Oil and Diet for the Treatment of Non-Alcoholic Steatohepatitis (NASH)

    Not yet reported University of Illinois Chicago 12 participants Est. completion 2010-10 1 site
    MASH Other conditions: Hepatic Steatosis
    View official trial listing →
  • Completed NCT NCT00891293

    A Second Open-Label Extension of a Double-Blind, Parallel, Phase IV Study to Assess the Efficacy and Safety of Adjunctive Lovaza® (Formerly Known as Omacor®) Therapy in Hypertriglyceridemic Subjects Treated With Antara™

    Not yet reported GlaxoSmithKline 93 participants Est. completion 2008-05 32 sites Stand-alone
    Other conditions: Hypertriglyceridemia
    View official trial listing →
  • Completed NCT NCT00903409

    Open-Label Extension of a Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Lovaza® and Simvastatin Therapy in Hypertriglyceridemic Subjects

    Not yet reported GlaxoSmithKline 188 participants Est. completion 2008-06-27 40 sites Stand-alone
    Other conditions: Hypertriglyceridemia
    View official trial listing →
  • Completed NCT NCT00915902

    Fish Oil Study for High Triglyceride Levels in Children

    Not yet reported, Not yet reported Babu Balagopal 42 participants Est. completion 2012-09 3 sites Stand-alone
    Other conditions: Hypertriglyceridemia
    View official trial listing →
  • Terminated NCT NCT00930527

    Omega-3-Fatty Acid on Joint Symptoms Inducted by Aromatase Inhibitors

    Not yet reported Columbia University 10 participants Est. completion 2011-05 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00931879

    Lovaza® and Microvascular Function in Type 2 Diabetes

    Not yet reported Eastern Virginia Medical School 44 participants Est. completion 2012-07 1 site
    Other conditions: Hypertriglyceridemia, Diabetic Neuropathy
    View official trial listing →
  • Status unknown NCT NCT00934219

    Triglyceride Lowering Study

    Not yet reported Jewish Hospital, Cincinnati, Ohio 25 participants Est. completion 2012-12 1 site
    Other conditions: Hypertriglyceridemia
    View official trial listing →
  • Terminated NCT NCT00935766

    Effect of Fish Oil (Omega-3 Fatty Acids) on Arteries

    Not yet reported Denver Health and Hospital Authority 76 participants Est. completion 2012-03 1 site
    Cardiovascular disease Other conditions: Metabolic Diseases, Endocrine System Diseases, Heart Disease, Vascular Diseases, Diabetes, Glucose Metabolism Disorders, Hypertension
    View official trial listing →
  • Status unknown NCT NCT00941642

    Placebo Controlled Study Using Lovaza as Treatment for Non-Alcoholic Fatty Liver Disease

    Not yet reported Huntington Medical Research Institutes 40 participants Est. completion 2012-09 1 site
    Other conditions: Non-Alcoholic Fatty Liver Disease
    View official trial listing →
  • Terminated NCT NCT00944229

    The Effect of Omega-3 Polyunsaturated Fatty Acids in Congestive Heart Failure

    Not yet reported Columbia University 58 participants Est. completion 2014-03 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT00959842

    Effects of Lovaza on Lipoprotein Composition and Function in Mild Hypertriglyceridemia

    Not yet reported, Not yet reported Sanford Research 15 participants Est. completion 2010-02 1 site Stand-alone
    Other conditions: Hypertriglyceridemia
    View official trial listing →
  • Completed NCT NCT01001767

    Pilot Placebo Controlled Study With Lovaza in Cardiovascular Disease

    Not yet reported University Hospitals Cleveland Medical Center 35 participants Est. completion 2010-06 1 site
    Other conditions: HIV Infections, Heart Disease
    View official trial listing →
  • Terminated NCT NCT01002118

    Feasibility Study of Omega-3 Fatty Acids in Dialysis Patients

    Not yet reported University of Iowa 1 participants Est. completion 2011-02-23 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01010399

    Boosted Lexiva With Lovaza Adjunctive Therapy in Hypertriglyceridemic, HIV-Infected Subjects

    Not yet reported Felizarta, Franco, M.D. 36 participants Est. completion 2010-11 1 site Stand-alone
    Other conditions: Hypertriglyceridemia, HIV Infection
    View official trial listing →
  • Completed NCT NCT01034540

    Effects of Prescription Omega-3 Acids on Glucose and Lipoprotein Lipids in Subjects With Hypertriglyceridemia

    Not yet reported Provident Clinical Research 23 participants Est. completion 2011-02 1 site
    Other conditions: Hypertriglyceridemia
    View official trial listing →
  • Completed NCT NCT01041521

    The Impact of Omega Three Fatty Acids on Vascular Function in HIV

    Not yet reported Tufts University 129 participants Est. completion 2015-08 1 site Stand-alone
    Other conditions: High Triglyceride Level, HIV Infection
    View official trial listing →
  • Status unknown NCT NCT01046604

    Pilot Study of Lovaza (Omega 3 Fatty Acids) to Improve Cardiac Antioxidant/Anti-inflammatory Profile Before Cardiac Surgery

    Not yet reported East Carolina University 24 participants Est. completion 2013-12 1 site
    Other conditions: Mitral Valve Regurgitation, Left Atrium Dilatation and Hypertrophy, Mitochondrial Dysfunction in the Heart, Cardiomyocyte Apoptosis, Cardiac Inflammation
    View official trial listing →
  • Completed NCT NCT01047501

    Effect of AMR101 (Ethyl Icosapentate) on Triglyceride (Tg) Levels in Patients on Statins With High Tg Levels (≥ 200 and < 500 mg/dL)

    Not yet reported Amarin Pharma Inc. 702 participants Est. completion 2011-02 80 sites
    Other conditions: Hypertriglyceridemia
    View official trial listing →
  • Completed NCT NCT01047683

    Efficacy and Safety of AMR101 (Ethyl Icosapentate) in Patients With Fasting Triglyceride (Tg) Levels ≥ 500 and ≤ 2000 mg/dL

    Not yet reported Amarin Pharma Inc. 229 participants Est. completion 2011-07 60 sites
    Other conditions: Hypertriglyceridemia
    View official trial listing →
  • Completed NCT NCT01048502

    Fenofibrate and Omega-3 Fatty Acid Modulation of Endotoxemia

    Not yet reported University of Pennsylvania 100 participants Est. completion 2011-05 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT01086163

    Effects of Omega-3 Fatty Acids on Platelets in Patients With Coronary Artery Disease With Hypertriglyceridemia

    HeartDrug Research LLC 30 participants Est. completion 2011-04 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01092390

    Go Fish: Omega-3 Fatty Acid Supplementation in Diabetes-Related Kidney Disease

    Not yet reported Johns Hopkins University 31 participants Est. completion 2011-05 1 site Stand-alone
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01107964

    Oral Omega-3 Fatty Acids in the Treatment of Dry Eye Syndrome

    Not yet reported Milton S. Hershey Medical Center 27 participants Est. completion 2015-06-15 1 site
    Other conditions: Dry Eye Syndrome
    View official trial listing →
  • Terminated NCT NCT01155336

    The Effects of Lovaza® in Acute Myocardial Infarction

    Not yet reported, Not yet reported University of Rochester 4 participants Est. completion 2011-05 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT01157780

    Parenteral Nutrition Associated Liver Disease: Early Markers and Therapy Wih Enteral Omega-3 Supplementation

    Not yet reported University of Tennessee 100 participants Est. completion 2014-12 1 site Stand-alone
    Other conditions: Parenteral Nutrition Associated Liver Disease
    View official trial listing →
  • Active, not recruiting NCT NCT01169259

    Vitamin D and Omega-3 Trial (VITAL)

    Not yet reported Brigham and Women's Hospital 25871 participants Est. completion 2031-03 1 site
    Cardiovascular disease Other conditions: Cancer
    View official trial listing →
  • Withdrawn NCT NCT01180764

    Effects of Lovaza on High Density Lipoprotein (HDL) Composition and Function in Hypertriglyceridemia

    Not yet reported University of Utah Est. completion 2012-10 1 site Stand-alone
    Other conditions: Hypertriglyceridemia
    View official trial listing →
  • Withdrawn NCT NCT01191177

    Investigational Study of Oral Fish Oil in Treating Parenteral Nutrition Associated Liver Disease

    Not yet reported, Not yet reported Boston Children's Hospital Est. completion 2012-01 1 site Stand-alone
    Other conditions: Liver Disease, Short Bowel Syndrome
    View official trial listing →
  • Completed NCT NCT01198275

    n-3 Polyunsaturated Fatty Acids (PUFAs) in the Prevention of Atrial Fibrillation

    Not yet reported Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 199 participants Est. completion 2008-05 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Status unknown NCT NCT01202812

    A Randomized Trial of LOVAZA in Pediatric Sickle Cell Disease (SCD)

    Not yet reported Thomas Jefferson University 48 participants Est. completion 2012-03 2 sites Stand-alone
    Other conditions: Sickle Cell Disease, HEMOGLOBIN SS, Hemoglobin S Beta-0 Thalassemia, Inflammation, Quality of Life
    View official trial listing →
  • Completed NCT NCT01208961

    Epanova® Compared to Lovaza® In a Pharmacokinetic, Single-dose, Evaluation

    Not yet reported AstraZeneca 54 participants Est. completion 2010-11 1 site
    Other conditions: Severe Hypertriglyceridemia
    View official trial listing →
  • Status unknown NCT NCT01216982

    Effects of Omega-3 EPA/DHA for Soldiers at Risk for Mood Disorders

    Not yet reported United States Department of Defense 256 participants Est. completion 2011-06 1 site
    Other conditions: Mood Disorders, Depression, Combat Disorders, Stress Disorders
    View official trial listing →
  • Completed NCT NCT01223703

    PUFAs and Left Ventricular Function in Heart Failure

    Not yet reported Università degli Studi di Brescia 133 participants Est. completion 2009-06 1 site
    Heart failure Other conditions: Dilated Cardiomyopathy
    View official trial listing →
  • Completed NCT NCT01252277

    Breast Cancer Risk Biomarkers in Premenopausal Women

    Not yet reported Carol Fabian, MD 36 participants Est. completion 2013-04 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01252290

    Breast Cancer Risk Biomarkers in Postmenopausal Women

    Not yet reported Carol Fabian, MD 35 participants Est. completion 2013-05 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01277237

    The Effect Of Omega-3 Fatty Acids on Non-alcoholic Fatty Liver Disease

    Not yet reported University of Edinburgh 50 participants Est. completion 2012-08 1 site
    Other conditions: Non Alcoholic Fatty Liver Disease
    View official trial listing →
  • Completed NCT NCT01282580

    Dietary Fish and Omega 3 Fatty Acids for Breast Cancer Prevention

    Not yet reported Ohio State University Comprehensive Cancer Center 25 participants Est. completion 2014-08 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT01301794

    Lovaza Mechanisms of Action

    Not yet reported Brigham and Women's Hospital 40 participants Est. completion 2014-08 1 site
    Other conditions: Moderate Hypertriglyceridemia.
    View official trial listing →
  • Completed NCT NCT01308957

    Fish Oil and Muscle Function

    Not yet reported Washington University School of Medicine 77 participants Est. completion 2014-12 1 site
    Other conditions: Sarcopenia
    View official trial listing →
  • Completed NCT NCT01350973

    Efficacy of TAK-085 in Participants With Hypertriglyceridemia

    Not yet reported Takeda 611 participants Est. completion 2010-12 Stand-alone
    Other conditions: Hypertriglyceridemia
    View official trial listing →
  • Completed NCT NCT01350999

    Long-term Efficacy and Safety Study of TAK-085 in Participants With Hypertriglyceridemia

    Not yet reported Takeda 503 participants Est. completion 2011-01 Stand-alone
    Other conditions: Hypertriglyceridemia
    View official trial listing →
  • Completed NCT NCT01367145

    OMEGA-3-Polyunsaturated Fatty-Acids (N3-Pufa) In Patients With Peripheral Arterial Disease

    Not yet reported Medical University of Vienna 71 participants Est. completion 2014-03 1 site
    Other conditions: Peripheral Arterial Disease
    View official trial listing →
  • Completed NCT NCT01422317

    Effects of High-dose n-3 Fatty Acids on Clinical Outcome and Serum Lipids - Omacor Following Acute Myocardial Infarction

    Not yet reported Helse Stavanger HF 300 participants Est. completion 2002-12 1 site
    Cardiovascular disease Other conditions: Coronary Disease
    View official trial listing →
  • Completed NCT NCT01431690

    Interaction of Epanova on Warfarin Pharmacokinetic and Anticoagulant Activity and Comparison of the Effects of Epanova and Lovaza on Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) After Low-fat Meals

    Not yet reported AstraZeneca 52 participants Est. completion 2011-10 1 site
    Other conditions: Hypertriglyceridemia
    View official trial listing →
  • Completed NCT NCT01492361

    A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High-Risk Patients With Hypertriglyceridemia and on Statin

    Not yet reported Amarin Pharma Inc. 8179 participants Est. completion 2018-05 410 sites
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT01526824

    Lovaza's Effect on Clopidogrel in a Neuro Population

    Not yet reported Millard Fillmore Gates Hospital 60 participants Est. completion 2013-09 1 site Stand-alone
    Cardiovascular disease Other conditions: Transient Ischemic Attack
    View official trial listing →
  • Status unknown NCT NCT01577056

    Postprandial Lipid Metabolism in Familial Hypercholesterolaemia:Effects of Fish Oils

    Not yet reported The University of Western Australia 30 participants Est. completion 2014-03 1 site
    Other conditions: Hypertriglyceridaemia, Familial Hypercholesterolaemia
    View official trial listing →
  • Completed NCT NCT01594983

    A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia

    Not yet reported Novartis Pharmaceuticals 58 participants Est. completion 2013-07 32 sites
    Other conditions: Non Familial Chylocmicronemia Syndrome (Non-FCS)
    View official trial listing →
  • Completed NCT NCT01596842

    Effect of Omega-3 Fatty Acid on Vitamin D Activation

    Not yet reported Dong-A University 17 participants Est. completion 2012-12 1 site
    Other conditions: Hemodialysis Patients, Vitamin D Insufficiency, Vitamin D Deficiency
    View official trial listing →
  • Completed NCT NCT01624727

    Slowing HEART diSease With Lifestyle and Omega-3 Fatty Acids

    Not yet reported Beth Israel Deaconess Medical Center 338 participants Est. completion 2015-01-15 2 sites
    Metabolic syndrome Other conditions: Coronary Heart Disease
    View official trial listing →
  • Completed NCT NCT01630213

    Impact of Vitamin D Supplementation on Cardiac Structure and Function

    Not yet reported Massachusetts General Hospital 1025 participants Est. completion 2021-06-30 1 site
    Cardiovascular disease
    View official trial listing →
  • Active, not recruiting NCT NCT01632761

    Effects of Vitamin D and Marine Omega-3 Fatty Acids on Anemia

    Not yet reported Brigham and Women's Hospital 2000 participants Est. completion 2025-12-28 1 site
    Other conditions: Anemia
    View official trial listing →
  • Completed NCT NCT01632878

    Omacor Plus Standard Therapies In Post Myocardial Infarction (MI) Subjects Evaluation: The OPTIMISE Observational Study

    Mylan Inc. 1531 participants Est. completion 2014-12 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01633177

    Study of Vitamin D and Omega-3 Supplementation for Preventing Diabetes

    Not yet reported Brigham and Women's Hospital 22220 participants Est. completion 2024-05-30 1 site
    Type 2 diabetes
    View official trial listing →
  • Active, not recruiting NCT NCT01653678

    Vitamin D and Omega-3 Hypertension Trial (VITAL Hypertension)

    Not yet reported Brigham and Women's Hospital 25875 participants Est. completion 2026-06 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01661764

    Fish Oil Supplementation, Nutrigenomics and Colorectal Cancer Prevention

    Not yet reported Vanderbilt University 141 participants Est. completion 2018-01-23 1 site
    Other conditions: Colorectal Adenomatous Polyps
    View official trial listing →
  • Completed NCT NCT01669915

    A Large Randomized Trial of Vitamin D, Omega-3 Fatty Acids and Cognitive Decline

    Not yet reported Brigham and Women's Hospital 3424 participants Est. completion 2021-12-31 1 site
    Other conditions: Cognitive Decline
    View official trial listing →
  • Completed NCT NCT01684722

    Vitamin D and Omega-3 Trial to Prevent and Treat Diabetic Kidney Disease

    Not yet reported University of Washington 1312 participants Est. completion 2019-11-08 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01686568

    Omega-3 Fatty Acids and Insulin Sensitivity

    Not yet reported Mayo Clinic 31 participants Est. completion 2015-06-08 1 site
    Other conditions: Insulin Resistance
    View official trial listing →
  • Completed NCT NCT01696435

    VITAL-DEP: Depression Endpoint Prevention in the VITamin D and OmegA-3 TriaL

    Not yet reported Brigham and Women's Hospital 18353 participants Est. completion 2025-03-31 1 site
    Other conditions: Depression, Depressive Symptoms, Mood
    View official trial listing →
  • Completed NCT NCT01704859

    VITamin D and OmegA-3 TriaL (VITAL): Fractures, Vitamin D and Genetic Markers

    Not yet reported Brigham and Women's Hospital 25871 participants Est. completion 2022-11-23 1 site
    Other conditions: Fractures
    View official trial listing →
  • Completed NCT NCT01712867

    The Effect of Phytosterol Esters of Omega-3 (Vayarol) Versus Omega-3 Acids Ethyl Esters in Reducing Triglyceride Levels

    Not yet reported Enzymotec 201 participants Est. completion 2014-12 1 site
    Other conditions: Patients With Hypertriglyceridemia
    View official trial listing →
  • Completed NCT NCT01725646

    An Efficacy and Safety Study of Omacor® in Taiwanese Hypertriglyceridemic Patients

    Not yet reported Excelsior 253 participants Est. completion 2013-08 4 sites
    Other conditions: Hypertriglyceridemia
    View official trial listing →
  • Active, not recruiting NCT NCT01728571

    LungVITamin D and OmegA-3 Trial (lungVITAL)

    Not yet reported Brigham and Women's Hospital 25871 participants Est. completion 2027-11 1 site
    Other conditions: COPD, Asthma, Pulmonary Function, Pneumonia
    View official trial listing →
  • Completed NCT NCT01744067

    The Effects of Omega-3 Fatty Acids in Renal Transplantation

    Not yet reported Oslo University Hospital 132 participants Est. completion 2015-12 2 sites
    Other conditions: Disorder Related to Renal Transplantation
    View official trial listing →
  • Completed NCT NCT01747447

    VITamin D and OmegA-3 TriaL: Effects on Bone Structure and Architecture (VITAL)

    Not yet reported Brigham and Women's Hospital 771 participants Est. completion 2023-08-02 1 site
    Other conditions: Bone Density, Body Composition, Bone Health
    View official trial listing →
  • Active, not recruiting NCT NCT01758081

    Effects of Vitamin D and Omega-3 Fatty Acids on Infectious Diseases and hCAP18 (VITAL Infection)

    Not yet reported Brigham and Women's Hospital 25874 participants Est. completion 2026-12 1 site
    Other conditions: Infections, Human Cathelicidin Antimicrobial Peptide (hCAP-18)
    View official trial listing →
  • Terminated NCT NCT01778647

    Omega-3 Fatty Acids as an Adjunctive Therapy for Stimulants in Children With ADHD

    Not yet reported Antonios Likourezos 15 participants Est. completion 2010-07 1 site Stand-alone
    Other conditions: Attention Deficit Hyperactivity Disorder
    View official trial listing →
  • Status unknown NCT NCT01782352

    Age-related Macular Degeneration (AMD) in the Vitamin D and Omega-3 Trial (VITAL)

    Not yet reported Brigham and Women's Hospital 25871 participants Est. completion 2024-09 1 site
    Other conditions: Age-related Macular Degeneration
    View official trial listing →
  • Withdrawn NCT NCT01784042

    Dietary Energy Restriction and Omega-3 Fatty Acids on Mammary Tissue

    Not yet reported Milton S. Hershey Medical Center Est. completion 2018-03 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT01785004

    Vitamin D and Omega-3 Adiposity Trial (VITAL Adiposity)

    Not yet reported Brigham and Women's Hospital 600 participants Est. completion 2022-07 1 site
    Other conditions: Adiposity
    View official trial listing →
  • Completed NCT NCT01813006

    Effect of Omega-3 Fatty Acid on Endothelial Function

    Not yet reported Nordlandssykehuset HF 34 participants Est. completion 2017-12 1 site
    Other conditions: Familial Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01813110

    Effects of a Prescription Omega-3 Fatty Acid Concentrate on Induced Inflammation

    Not yet reported Penn State University 21 participants Est. completion 2015-04 1 site
    Other conditions: Inflammatory Responses
    View official trial listing →
  • Completed NCT NCT01821833

    Omega-3 Fatty Acid in Treating Pain in Patients With Breast or Ovarian Cancer Receiving Paclitaxel

    Not yet reported New Mexico Cancer Research Alliance 60 participants Est. completion 2022-08-03 2 sites
    Other conditions: Breast Cancer, Ovarian Neoplasm, Pain
    View official trial listing →
  • Completed NCT NCT01823991

    COGNUTRIN in Breast Cancer Survivors

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute 36 participants Est. completion 2018-05-02 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT01880463

    Dry Eye Disease in the Vitamin D and Omega-3 Trial (VITAL)

    Not yet reported Brigham and Women's Hospital 25875 participants Est. completion 2021-12
    Other conditions: Dry Eye Disease
    View official trial listing →
  • Completed NCT NCT01888211

    Effect of Omega 3 Fatty Acids on Vascular Function

    Not yet reported University of Edinburgh 20 participants Est. completion 2009-06 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01894581

    Effects of Dietary Omega-3 Fatty Acids on Reproductive Hormones in Obese Women

    Not yet reported University of Colorado, Denver 39 participants Est. completion 2014-12 1 site Stand-alone
    Other conditions: Obesity, Fertility
    View official trial listing →
  • Completed NCT NCT01929070

    A Pilot Study to Evaluate the Pharmacokinetics of Omega-3 Between Rosuvastatin and Omega-3 Coadministration and HCP1007

    Not yet reported Hanmi Pharmaceutical Company Limited 12 participants Est. completion 2013-03 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02010359

    Fish Oils and Adipose Inflammation Reduction

    Not yet reported University of Pennsylvania 29 participants Est. completion 2017-07-01 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Status unknown NCT NCT02035215

    Phase 3 Study to Evaluate the Efficacy and Safety of Omega-3-acids Ethylesters 90 in Type Ⅱb Hyperlipidemia

    Not yet reported Kuhnil Pharmaceutical Co., Ltd. 80 participants Est. completion 2014-12 4 sites
    Other conditions: Hyperlipidemia, Familial Combined
    View official trial listing →
  • Completed NCT NCT02113163

    PK Study Comparing Metformin Eicosapentaenoate to a Combined Dose of Metformin Hydrochloride and Ethyl Ester EPA

    Not yet reported Thetis Pharmaceuticals LLC 32 participants Est. completion 2014-07 1 site
    Other conditions: Diabetes Mellitus, Non-Insulin-Dependent, Hypertriglyceridemia
    View official trial listing →
  • Completed NCT NCT02153073

    Evaluation of the Safety and Efficacy of Long-term Use of Omega-3 Fatty Acid Ethyl Esters

    Takeda 3084 participants Est. completion 2017-05-31 2 sites
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT02155816

    Omega 7 + 3 Combination and Systemic Inflammation

    Not yet reported Appalachian State University 68 participants Est. completion 2014-08 1 site
    Other conditions: Inflammation
    View official trial listing →
  • Active, not recruiting NCT NCT02178410

    VITAL Rhythm Study

    Not yet reported Brigham and Women's Hospital 25119 participants Est. completion 2027-10 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02189252

    An Open-Label Crossover Study to Compare the Relative Bioavailability, Efficacy and Safety of Epanova® and Lovaza® in Men and Women With a History of Pancreatitis

    Not yet reported AstraZeneca 30 participants Est. completion 2015-07 4 sites
    Other conditions: Severe Hypertriglyceridemia
    View official trial listing →
  • Completed NCT NCT02285166

    Specified Drug-use Survey of the Granular Capsule Formulation of Omega-3 Fatty Acid Ethyl Esters: OCEAN3

    Takeda 15330 participants Est. completion 2020-07-14 2 sites
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT02305355

    Efficacy and Safety of Prescription Omega-3 Fatty Acid Added to Stable Statin Therapy in Patients With Type 2 Diabetes and Hypertriglyceridemia

    Not yet reported Kuhnil Pharmaceutical Co., Ltd. 68 participants Est. completion 2011-02 1 site
    Type 2 diabetes Other conditions: Hypertriglycemia
    View official trial listing →
  • Completed NCT NCT02370537

    A Study to Investigate How Common Pancreatic Exocrine Insufficiency (PEI) is in Patients With Type 2 Diabetes and Also to Investigate the Uptake of a Single Dose of EPANOVA® or OMACOR® in Patients With Different Degrees of PEI

    Not yet reported AstraZeneca 490 participants Est. completion 2015-11 22 sites Stand-alone
    Type 2 diabetes Other conditions: Exocrine Pancreatic Insufficiency
    View official trial listing →
  • Status unknown NCT NCT02625870

    Omega-3-Acid Ethyl Esters 90 Soft Capsules for Lowering Very High Triglycerides

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 240 participants Stand-alone
    Other conditions: Hypertriglyceridemia
    View official trial listing →
  • Completed NCT NCT02757872

    Effects of Vitamin D and Fish Oil on the Kidney in Hypertensives

    Not yet reported Albert Einstein College of Medicine 2232 participants Est. completion 2022-03-31 1 site
    Other conditions: Hypertension, Kidney Diseases
    View official trial listing →
  • Completed NCT NCT02824432

    Exploratory Study of the Effect of Omega-3-acid Ethyl Esters (TAK-085) on Vascular Endothelial Function in Patients With Hyperlipidemia by Flow Mediated Dilation

    Not yet reported Takeda 37 participants Est. completion 2017-08-19 4 sites Stand-alone
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT02839902

    Exploratory Study of the Effects of Omega-3-acid Ethyl Esters on the Lipid and Lipoprotein Profile in the Blood

    Not yet reported Takeda 53 participants Est. completion 2017-08-30 7 sites Stand-alone
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT02865044

    Study to Evaluate the Acute Bioavailability of EPA and DHA From a DietarySupplement in Healthy Men and Women

    Not yet reported Calanus 18 participants Est. completion 2015-04 1 site
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT02899741

    Efficacy of Omega-3 as Adjunctive Therapy for Medically Intractable Epilepsy: A Prospective Open-label Pilot Study

    Not yet reported Seoul National University Hospital 30 participants Est. completion 2018-11 1 site
    Other conditions: Epilepsy
    View official trial listing →
  • Withdrawn NCT NCT02990091

    Derivatives of Omega-3 HUFA as Biomarkers of Traumatic Brain Injury

    Not yet reported University of Pennsylvania Est. completion 2023-12 1 site Stand-alone
    Other conditions: TBI
    View official trial listing →
  • Completed NCT NCT02996240

    Breast, Omega 3 Free Fatty Acid, Ph 0

    Not yet reported The University of Texas Health Science Center at San Antonio 21 participants Est. completion 2021-02-22 1 site
    Other conditions: Breastcancer
    View official trial listing →
  • Completed NCT NCT03018041

    The Long-term Effect of Marine Omega-3 Fatty Acid Supplementation in Renal Transplantation

    Not yet reported Joe Chan 174 participants Est. completion 2025-03-22 6 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Withdrawn NCT NCT03167164

    QUILT-3.045: NANT Merkel Cell Carcinoma (MCC) Vaccine: Combination Immunotherapy in Subjects With MCC Who Have Progressed on or After PD-L1 Therapy

    Not yet reported, Not yet reported ImmunityBio, Inc. Est. completion 2021-12-28 Stand-alone
    Other conditions: Merkel Cell Carcinoma
    View official trial listing →
  • Withdrawn NCT NCT03167177

    QUILT-3.046: NANT Melanoma Vaccine: Combination Immunotherapy in Subjects With Melanoma Who Have Progressed On or After Chemotherapy and PD-1/PD-L1 Therapy

    Not yet reported, Not yet reported ImmunityBio, Inc. Est. completion 2021-12-28 Stand-alone
    Other conditions: Melanoma
    View official trial listing →
  • Withdrawn NCT NCT03169738

    QUILT-3.044: NANT Non-small Cell Lung Cancer (NSCLC) Vaccine: Combination Immunotherapy in Subjects With NSCLC Who Have Progressed After Treatment With PD-1/PD-L1 Inhibitors

    Not yet reported, Not yet reported ImmunityBio, Inc. Est. completion 2021-12-28 Stand-alone
    Other conditions: Non-small Cell Lung Cancer
    View official trial listing →
  • Withdrawn NCT NCT03169764

    QUILT-3.047: NANT Head and Neck Squamous Cell Carcinoma (HNSCC) Vaccine: Combination Immunotherapy in Subjects With HNSCC Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy

    Not yet reported, Not yet reported ImmunityBio, Inc. Est. completion 2021-12-28 Stand-alone
    Other conditions: Head and Neck Squamous Cell Carcinoma
    View official trial listing →
  • Withdrawn NCT NCT03169777

    QUILT-3.050: NANT Colorectal Cancer (CRC) Vaccine: Combination Immunotherapy in Subjects With Recurrent or Metastatic CRC

    Not yet reported, Not yet reported ImmunityBio, Inc. Est. completion 2021-12-28 Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Withdrawn NCT NCT03169790

    QUILT-3.052: NANT Non-Hodgkin Lymphoma (NHL) Vaccine: Combination Immunotherapy in Subjects With Relapsed CD20-positive NHL

    Not yet reported, Not yet reported ImmunityBio, Inc. Est. completion 2021-12-23 Stand-alone
    Other conditions: Non Hodgkin Lymphoma
    View official trial listing →
  • Withdrawn NCT NCT03175666

    QUILT-3.049: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Combination Immunotherapy in Subjects With TNBC Who Have Progressed on or After Anthracycline-based Chemotherapy

    Not yet reported, Not yet reported ImmunityBio, Inc. Est. completion 2021-12-28 Stand-alone
    Other conditions: Triple Negative Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT03197571

    QUILT-3.048: NANT Urothelial Cancer Vaccine: Combination Immunotherapy in Subjects With Urothelial Cancer Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy

    Not yet reported, Not yet reported ImmunityBio, Inc. Est. completion 2021-12-28 Stand-alone
    Other conditions: Urothelial Carcinoma
    View official trial listing →
  • Withdrawn NCT NCT03197584

    QUILT-3.051: NANT Ovarian Cancer Vaccine: Combination Immunotherapy in Subjects With Epithelial Ovarian Cancer Who Have Progressed on or After Standard-of-care (SoC) Therapy

    Not yet reported, Not yet reported ImmunityBio, Inc. Est. completion 2021-12-28 Stand-alone
    Other conditions: Ovarian Cancer
    View official trial listing →
  • Terminated NCT NCT03329248

    QUILT-3.060: NANT Pancreatic Cancer Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy

    Not yet reported, Not yet reported ImmunityBio, Inc. 6 participants Est. completion 2019-11-01 1 site Stand-alone
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Terminated NCT NCT03387098

    QUILT-3.070:Pancreatic Cancer Vaccine: Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy

    Not yet reported, Not yet reported ImmunityBio, Inc. 4 participants Est. completion 2019-01-15 1 site Stand-alone
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT03415152

    A Prospective Observational Program Using Digital Technology Tools to Enhance Patient Adherence to Omacor Therapy

    Abbott 3000 participants Est. completion 2019-07-01 93 sites
    Cardiovascular disease Other conditions: Hypertriglyceridemia
    View official trial listing →
  • Status unknown NCT NCT03438955

    Phase I Drug-drug Interaction of Omega-3 and Atorvastatin

    Not yet reported DongKoo Bio & Pharma 48 participants Est. completion 2018-08-31 1 site
    Other conditions: Hyperlipidemia, Hypertriglyceridemia
    View official trial listing →
  • Completed NCT NCT03443076

    Bioavailability of EPA + DHA in a SMEDS Formulation

    Not yet reported Midwest Center for Metabolic and Cardiovascular Research 24 participants Est. completion 2018-04-15 2 sites
    Other conditions: Bioavailability
    View official trial listing →
  • Active, not recruiting NCT NCT03598309

    Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute 19 participants Est. completion 2026-05 1 site
    Other conditions: Lung Diseases, Lung Cancer, Protection Against
    View official trial listing →
  • Status unknown NCT NCT03831698

    Omega 3 Fatty Acids in Colorectal Cancer (CRC) Prevention in Patients With Lynch Syndrome (COLYNE)

    Not yet reported University of Kansas Medical Center 21 participants Est. completion 2024-08 1 site
    Other conditions: Colorectal Cancer, Lynch Syndrome
    View official trial listing →
  • Completed NCT NCT04070833

    Effects of Vitamin D and Omega-3 on Cerebrovascular Disease

    Not yet reported Brigham and Women's Hospital 290 participants Est. completion 2018-09-17
    Cardiovascular disease Other conditions: Vitamin D
    View official trial listing →
  • Completed NCT NCT04177680

    Pharmacodynamic Effects of a Free-Fatty Acid Formulation of Omega-3 Pentaenoic Acid in Adults With Hypertriglyceridemia

    Not yet reported Matinas BioPharma Nanotechnologies, Inc. 100 participants Est. completion 2021-01-18 8 sites
    Other conditions: Hypertriglyceridemia
    View official trial listing →
  • Status unknown NCT NCT04242004

    Effects of Docosahexanoic Acid on Neurocognitive Impairment in HIV-infected Patients

    Not yet reported, Not yet reported Fudan University 88 participants Est. completion 2020-05-01 1 site Stand-alone
    Other conditions: Neurocognitive Impairment
    View official trial listing →
  • Completed NCT NCT04268134

    Altering Lipids for Tolerance of Aromatase Inhibitor Therapy

    Not yet reported University of Michigan Rogel Cancer Center 77 participants Est. completion 2024-02-27 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT04308889

    Pro-Resolving Mediators in Acute Inflammation in Humans

    Not yet reported Brigham and Women's Hospital 19 participants Est. completion 2022-02-22 1 site Stand-alone
    Other conditions: Inflammation; Skin, Resolution, Blister
    View official trial listing →
  • Status unknown NCT NCT04386577

    Effects of Vitamin D and Omega-3 Supplementation on Telomeres in VITAL

    Not yet reported Augusta University 1054 participants Est. completion 2021-04-30 1 site
    Other conditions: Aging
    View official trial listing →
  • Completed NCT NCT04521465

    Safety and Efficacy of NovaTears® + Omega-3 (0.2%) Eye Drops on Signs and Symptoms of Dry Eye

    Novaliq GmbH 36 participants Est. completion 2021-02-17 2 sites
    Other conditions: Evaporative Dry Eye Disease
    View official trial listing →
  • Active, not recruiting NCT NCT04573946

    VITamin D and OmegA-3 TriaL: Interrelationship of Vitamin D and Vitamin K on Bone (VITAL)

    Not yet reported Brigham and Women's Hospital 25871 participants Est. completion 2026-12-31 1 site
    Other conditions: Bone Density, Bone Health, Fractures
    View official trial listing →
  • Completed NCT NCT04756180

    An Efficacy and Safety Study of Omega-3-acid Ethyl Ester in Chinese Subjects With Hypertriglyceridemia.

    Not yet reported Abbott 248 participants Est. completion 2019-04
    Other conditions: Hypertriglyceridemia
    View official trial listing →
  • Status unknown NCT NCT04907864

    Effect of Multi-modal Intervention Care on Cachexia in Patients With Advanced Cancer Compared to Conventional Management (MIRACLE)

    Not yet reported Kil Yeon Lee 112 participants Est. completion 2022-06-30 1 site
    Other conditions: Gastric Cancer, Colorectal Cancer, Pancreatic Cancer, Biliary Tract Cancer, Lung Cancer, Precachexia, Cachexia
    View official trial listing →
  • Terminated NCT NCT05281562

    Immunonutrition for Diabetic Foot Ulcers

    Not yet reported, Not yet reported Prisma Health-Midlands 1 participants Est. completion 2023-03-20 1 site Stand-alone
    Other conditions: Diabetes Mellitus, Diabetic Peripheral Neuropathy, Diabetic Foot Ulcer
    View official trial listing →
  • Completed NCT NCT05613803

    Poly-unsaturated Fats for Improving Nasal Polyps and Asthma

    Not yet reported Norfolk and Norwich University Hospitals NHS Foundation Trust 18 participants Est. completion 2026-01-31 1 site
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT06343285

    Upper Limb Tremor Reduction in Essential Tremor Patients

    Not yet reported Encora, Inc. 71 participants Est. completion 2024-11-12 1 site
    Other conditions: Essential Tremor
    View official trial listing →
  • Terminated NCT NCT06434948

    The Effect of Omega 3 Supplementation on Postoperative Delirium in Elderly Patients Undergoing Major Cardiac Surgery

    Not yet reported University of Missouri-Columbia 1 participants Est. completion 2026-04-29 1 site
    Other conditions: Postoperative Delirium
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Omega-3-Acid Ethyl Esters, Lovaza

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.